These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quinidine but not disopyramide prolongs cardiac Purkinje fiber action potentials after a pause. Bursill JA; Wyse KR; Campbell TJ J Cardiovasc Pharmacol; 1994 May; 23(5):833-7. PubMed ID: 7521469 [TBL] [Abstract][Full Text] [Related]
3. Action potential prolongation exhibits simple dose-dependence for sotalol, but reverse dose-dependence for quinidine and disopyramide: implications for proarrhythmia due to triggered activity. Wyse KR; Ye V; Campbell TJ J Cardiovasc Pharmacol; 1993 Feb; 21(2):316-22. PubMed ID: 7679168 [TBL] [Abstract][Full Text] [Related]
4. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization. Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973 [TBL] [Abstract][Full Text] [Related]
5. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents. Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351 [TBL] [Abstract][Full Text] [Related]
6. Differential effects on action potential duration of class IA, B and C antiarrhythmic drugs: modulation by stimulation rate and extracellular K+ concentration. Campbell TJ; Wyse KR; Pallandi R Clin Exp Pharmacol Physiol; 1991 Aug; 18(8):533-41. PubMed ID: 1655321 [TBL] [Abstract][Full Text] [Related]
7. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies. Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185 [TBL] [Abstract][Full Text] [Related]
8. Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes. Spinelli W; Moubarak IF; Parsons RW; Colatsky TJ Cardiovasc Res; 1993 Sep; 27(9):1580-91. PubMed ID: 8287434 [TBL] [Abstract][Full Text] [Related]
9. Potassium channel openers antagonize the effects of class III antiarrhythmic agents in canine Purkinje fiber action potentials. Implications for prevention of proarrhythmia induced by class III agents. Kondo M; Tsutsumi T; Mashima S Jpn Heart J; 1999 Sep; 40(5):609-19. PubMed ID: 10888381 [TBL] [Abstract][Full Text] [Related]
10. Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers. Lu HR; Mariën R; Saels A; De Clerck F J Cardiovasc Electrophysiol; 2001 Jan; 12(1):93-102. PubMed ID: 11204092 [TBL] [Abstract][Full Text] [Related]
11. Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization. Roden DM Eur Heart J; 1993 Nov; 14 Suppl H():56-61. PubMed ID: 8293755 [TBL] [Abstract][Full Text] [Related]
12. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. Davidenko JM; Cohen L; Goodrow R; Antzelevitch C Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391 [TBL] [Abstract][Full Text] [Related]
13. Pirmenol, a new antiarrhythmic drug with potassium- and sodium-channel blocking activity; a voltage-clamp study in rabbit Purkinje fibres. Reichardt B; Konzen G; Hauswirth O Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):462-71. PubMed ID: 2164163 [TBL] [Abstract][Full Text] [Related]
14. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111 [TBL] [Abstract][Full Text] [Related]
15. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. Roden DM; Hoffman BF Circ Res; 1985 Jun; 56(6):857-67. PubMed ID: 4006095 [TBL] [Abstract][Full Text] [Related]
16. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference? Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363 [TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia. Buchanan LV; Kabell G; Brunden MN; Gibson JK J Cardiovasc Pharmacol; 1993 Oct; 22(4):540-9. PubMed ID: 7505355 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry. Mirro MJ; Watanabe AM; Bailey JC Circ Res; 1981 Jun; 48(6 Pt 1):867-74. PubMed ID: 7226447 [TBL] [Abstract][Full Text] [Related]
19. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide. Nattel S; Bailey JC J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270 [TBL] [Abstract][Full Text] [Related]
20. The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium. Gough WB; el-Sherif N Cardiovasc Res; 1989 Jun; 23(6):554-9. PubMed ID: 2590928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]